You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ)擬與廣東省科學技術廳成立精準醫療聯合基金項目
格隆匯 11-23 20:05

格隆匯11月23日丨陽普醫療(300030.SZ)公佈,2020年11月23日,公司召開第五屆董事會第六次會議,審議通過了《關於與廣東省科學技術廳成立精準醫療聯合基金項目的議案》。為深入實施創新驅動發展戰略,充分發揮廣東省基礎研究與應用基礎研究基金(以下簡稱“省基金”)導向作用,促進基礎研究、應用基礎研究與產業化對接融通,進一步提升公司在精準醫療領域的創新能力,深化公司創新人才隊伍建設,公司擬與廣東省科學技術廳、廣東省基礎與應用基礎研究基金委員會簽署《廣東省基礎與應用基礎研究基金精準醫療聯合基金協議書》,三方共同參與實施廣東省基礎與應用基礎研究基金精準醫療聯合基金(以下簡稱“精準醫療聯合基金”)。協議約定自2021年至2023年,廣東省科學技術廳每年投入150萬元,公司每年以公益捐贈方式投入500萬元,每年共計650萬元,三年合計1950萬元,用於精準醫療基金項目實施。

精準醫療、智慧醫療和細胞治療戰略是公司的核心發展戰略,當前國內相關產業已經進入了技術發展“深水區”,迫切需要通過聯合臨牀醫療機構進行基礎研究與應用研究,幫助公司精準治療產品、智慧醫療產品和細胞治療產品取得技術突破。精準醫療聯合基金是省基金的組成部分,精準醫療聯合基金的實施,有利於公司深入實施創新驅動發展戰略,積極參與精準醫療的創新性基礎研究,深化企業創新人才隊伍建設,提升企業的原始創新能力;同時聯合醫療機構進行產品升級改進,將進一步提升公司產品的臨牀研究效率,促進公司自身的發展與創新,鞏固公司的行業地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account